is glp-1 a biologic Frontiers GLP 1 Drug Biosimilar Market

We found persistence varied significantly among the GLP-1 products with once weekly injectable semaglutide (Ozempic) having the highest median persistency at 9 months followed by weekly injectable dulaglutide (Trulicity) at 8 months with daily injectable liraglutide (Saxenda and Victoza) products having the lowest median persistence at 4 months

The Oral route of administration segment is anticipated to be the fastest-growing category with a CAGR of 10.2% from 2026 to 2033, driven by growing patient preference for non-injectable therapies, improving treatment compliance, and ongoing advancements in oral peptide drug delivery technologies

Preclinical evidence indicates that liraglutide can modify bile acid profiles and gut signaling independently of feeding behavior [114]

Outcomes may be influenced by initial weight, overall health, and the commitment to maintaining a healthy lifestyle

At TrimRx, we believe that informed decisions are the foundation of any successful health journey

Liraglutide therapy was continued for further three months and then switched to semaglutide owing to poor clinical results